SAN DIEGO, Oct. 26, 2017 /Weed Wire/ – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that subsidiary HempMeds® Mexico Executive Raúl Elizalde has been invited to speak on behalf of the family of companies, to the U.N. at the World Health Organization’s (WHO) International Drug Scheduling; Convention on Psychotropic Substances; Single Convention on Narcotic Drugs in Geneva, Switzerland, on Nov. 6, 2017.
Tag Archives: MJNA
Medical Marijuana, Inc. Announces State of Mexico’s Historic Purchase of Company’s Cannabis Product for Its Citizens
SAN DIEGO, Aug. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that the State of Mexico’s government has purchased the company’s Real Scientific Hemp Oil-X™ (RSHO-X™) CBD hemp oil products from its subsidiary HempMeds Mexico® to treat 11 of its citizens suffering from varying indications including Refractory Epilepsy and Lennox Gastaut-Syndrome.
SEC Calls Hemp Oil Fraud on Public Company
On June 15, 2017, the United States Securities and Exchange Commission called hemp oil fraud on a public company, filing a complaint in federal court that claims CV Sciences (OTCQB:CVSI) , formerly known as CannaVEST, and its CEO, Michael Mona, Jr., intentionally overstated the company’s total assets.
SeeThruEquity Initiates Coverage On Medical Marijuana, Inc. Investment Company AXIM Biotech (OTC: AXIM) With A Target Price Of $17.00
SAN DIEGO, Calif., May 17, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM) received coverage initiation from SeeThruEquity, a leading independent equity research firm focused on smallcap and microcap public companies, with a price target of $17.00.
Medical Marijuana, Inc. Major Investment AXIM Biotech Enters Term Sheet Agreement With U.S. API Company To Develop Bioequivalent Product To Marinol
SAN DIEGO, Calif., March 28, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB: AXIM), has entered into a Term Sheet Agreement with a U.S.-based controlled-substances API (Active Pharmaceutical Ingredient) production company to develop a dronabinol-based functional, controlled-release chewing gum product based on AXIM IP and technology.
Medical Marijuana, Inc. Investment AXIM Biotech Retains Ora To Manage Upcoming Product Development And Clinical Trials On Glaucoma And Dry Eye Indications
NEW YORK, March 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC: AXIM), a world leader in cannabinoid research and development, has retained the services of Ora®, Inc.,
Study Results: Medical Marijuana, Inc. Subsidiary HempMeds Mexico Announces Release of Study Using Its Real Scientific Hemp Oil-X to Treat Epileptic Children
SAN DIEGO, Calif., March 14, 2017 /Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Mexico is holding a press conference in Mexico City, Mexico, today to reveal the positive results of a recent study conducted by renowned Mexican physician Dr. Saul Garza Morales on the effects of the Company’s Real Scientific Hemp Oil-X™ (RSHO-X™) product in treating children with severe epilepsy.
Medical Marijuana, Inc. Investment Axim Biotech Announces Enrolled Patients Begin Phase II Trial for the Treatment of Irritable Bowel Syndrome (IBS) with CanChew Plus Cannabidiol (CBD) Chewing Gum
NEW YORK, March 7, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and commenced its Phase II clinical trial for the treatment of irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum.
Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown
SAN DIEGO, Calif., March 1, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by recent statements from Trump administration officials hinting at a crackdown on recreational marijuana.
Medical Marijuana, Inc. Receives Brazilian Government Approval for Treatment of Autism Patient Using, Subsidiary, HempMeds® Brasil, Flagship Product RSHO™
SAN DIEGO, Calif., March 3, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States subsidiary, HempMeds® Brasil, today announced that the Brazilian government approved a prescription for the Company’s cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country with Autism Spectrum Disorder (ASD).
Multiple Sclerosis Approval: Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Receives Brazilian Government Permission for Import of Flagship Product RSHO™
SAN DIEGO, Calif., Feb. 21, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat patients in the country suffering from Multiple Sclerosis.
Medical Marijuana Inc. Subsidiary, HempMeds, Announces New Affiliate Program Showcasing Customer Loyalty
SAN DIEGO, Calif., Feb. 13, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds® is announcing a new affiliate program showcasing customer loyalty by allowing them to earn a commission by referring customers to the company.
Alzheimer’s Patient Receives Brazilian Government Permission to be Treated with Medical Marijuana, Inc. Subsidiary, HempMeds® Brasil, Flagship Product RSHO™
SAN DIEGO, Calif., Feb., 7, 2017/Weed Wire/ — Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, subsidiary, HempMeds® Brasil today announced that the Brazilian government has authorized a doctor’s prescription for the Company’s hemp cannabidiol (CBD) oil product Real Scientific Hemp Oil™ (RSHO™) to treat a patient in the country suffering from Alzheimer’s disease.
Medical Marijuana Inc. Subsidiary Kannaway® Announces Launch of a New Product— “Kannaway® Gold Premium Hemp Oil”
SAN DIEGO, Jan. 25, 2017 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA), announced today that its subsidiary Kannaway® LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has unveiled a new premium hemp oil product – Kannaway Gold.
Medical Marijuana, Inc. Subsidiary HempMeds Mexico® Receives COFEPRIS Permission for Flagship Product RSHO-X™ Usage for Cancer Patient
SAN DIEGO, Jan. 24, 2017/Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary HempMeds Mexico® has received permission from Mexico’s health authority COFEPRIS to import their flagship product Real Scientific Hemp Oil-X™ (RSHO-X™) to treat a patient for their pain associated with cancer treatments and for their general well-being.
Medical Marijuana, Inc. Subsidiary Kannaway® Announces Exclusive Red Carpet Event in Atlanta, Georgia
SAN DIEGO, Jan. 13, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet Event in Atlanta, Ga., this weekend.
Medical Marijuana, Inc. Subsidiary, HempMeds(R) Brasil Announces Groundbreaking Distribution Partnership with Paragon HealthCare BR
Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, has announced a groundbreaking partnership between their subsidiary, HempMeds® Brasil and Paragon HealthCare BR, one of the leading global wholesale distributors of pharmaceutical products.
Forbes Features Medical Marijuana, Inc. in Article Citing Company’s Sales Data After Starting CBD Market ‘That Could Grow 700% by 2020’
SAN DIEGO, Dec. 14, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company, its products and investments were featured in a Forbes article focused on the current cannabidiol (CBD) market size and anticipated massive growth.
Medical Marijuana, Inc.’s Investment Axim(R) Biotech Files IP Application on Proprietary Method to Extract High-Purity THC
SAN DIEGO, Nov. 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC PINK: AXIM) has filed an IP application with the World Intellectual Property Organization.
Medical Marijuana, Inc. Subsidiary HempMeds(R) Mexico Begins Distribution of Flagship Product Real Scientific Hemp Oil(TM) to Colombian Market
SAN DIEGO, Calif., Nov. 28, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico, the first and only company with approval from COFEPRIS to legally import a cannabis product into Mexico, has begun distributing Real Scientific Hemp Oil™ (RSHO™) to Colombia.
Medical Marijuana, Inc.’s Kannaway, LLC Launches Refresh of World-Renowned Brand at ‘Genesis’ Event in San Diego
SAN DIEGO, Calif., Nov. 21, 2016 /Weed Wire/ — Medical Marijuana, Inc. announced today that its portfolio company Kannaway launched a refresh of its world-renowned brand at its `Genesis: People, Purpose, Passion’ event in San Diego this November.
Medical Marijuana, Inc. and Subsidiary HempMeds Partner With CannaNative(TM) to Produce First-Ever Cannabis Product Line for Native American Marketplace
SAN DIEGO, Calif., Aug. 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) and its subsidiary HempMeds® announced today a partnership with CannaNative™, LLC (“CannaNative™”) to produce the first-ever cannabis product line for the Native American marketplace.
Medical Marijuana, Inc.’s Subsidiary HempMeds(R) Mexico to Sponsor and Exhibit at Expoweed Conference in Mexico City
SAN DIEGO, Calif., Aug. 12, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its subsidiary HempMeds® Mexico is sponsoring and exhibiting at the Aug. 12-14 ExpoWeed Conference, the first-ever cannabis conference to be held in Mexico.
Medical Cannabis Activist Raul Elizalde to Join Medical Marijuana, Inc. at Southern California Cannabis Conference and Expo
SAN DIEGO, Aug. 3, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that medical cannabis activist Raul Elizalde of Mexico will join Company representatives at the Southern California Cannabis Conference and Expo (SocalCCExpo) at the San Diego Convention Center to discuss his fight to unify the voices of families and patients in need of medical cannabis in Mexico.
Medical Marijuana, Inc. Hires New Director of Human Resources to Support Company’s Rapid Growth, International Expansion
SAN DIEGO, Aug. 1, 2016/Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team today announced that Melissa Temple-Agosta has been hired as Director of Human Resources, reporting directly to Senior Vice President of Operations Blake Schroeder.
Medical Marijuana, Inc. Now Hiring for Sales and Marketing Positions for Booming Cannabis Industry
SAN DIEGO, July 28, 2016 /Weed Wire/ — Medical Marijuana, Inc.’s (OTC PINK: MJNA) management team announced today that it’s currently hiring for open sales and marketing positions, as the Company continues its rapid expansion.
Medical Marijuana, Inc. Portfolio Company Kannalife Featured in Sports Illustrated Article About Research That Could Be “Future New Wave of Medicine”
SAN DIEGO, Calif., July 15, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that its portfolio company Kannalife Sciences, Inc. was the focus of a Sports Illustrated online article about how the breakthrough cannabinoid research the Company is conducting could be the “future new wave of medicine” for traumatic brain injuries.
CFN Media Examines Medical Marijuana, Inc.’s Investment in AXIM Biotechnolgies’ Groundbreaking CBD and CBG Research
REDONDO, Calif., July 14, 2016 /Weed Wire/ — CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article and interview discussing Medical Marijuana Inc.’s (OTC PINK: MJNA) major investment in AXIM Biotechnologies.
Medical Marijuana, Inc. Receives New Permit to Export Into Paraguay, Plans New Latin America Expansion
SAN DIEGO, Calif., July 5, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that the Paraguay government has issued a new import permit for the Company’s flagship product Real Scientific Hemp Oil™ (RSHO™) for a new patient in the country.
Recent Developments in Cannabis Stocks
There have been some developments in a handful of cannabis related companies in the past few days.
Medical Marijuana, Inc. Receives 22 More Permits to Export Into Estimated $10-12 Billion Market in Mexico
SAN DIEGO, June 28, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC PINK: MJNA) announced today that Mexico’s government has approved 22 additional import permits for Real Scientific Hemp Oil-X™ (RSHO-X™), expanding the Company’s foothold into a market projected to eventually reach $10-12 billion annually.
SEC Charges ‘King Of Pot’ With Investment Fraud
Federal securities regulators have filed a complaint against Bruce Perlowin that charges the CEO of publicly-traded Hemp Inc of committing a long-running fraud by evading securities registration provisions and selling hundreds of millions of unregistered shares.
Medical Marijuana, Inc. (MJNA) Appoints Blake N. Schroeder, Esq., As Vice President of Operations
SAN DIEGO, March 29, 2016 /Weed Wire/ — Medical Marijuana, Inc. (OTC: MJNA) is proud to announce to shareholders and the public that the global industrial hemp investor and innovator has appointed Blake N. Schroeder, Esq., as Vice President of Operations at Medical Marijuana, Inc.
Brazil’s Government Health Agency Approves Patient’s Request for Medical Marijuana, Inc.’s RSHO™ for a New Indication: Parkinson’s Disease
SAN DIEGO,Nov. 18, 2015 /Weed Wire/ — Medical Marijuana, Inc. is pleased to announce to shareholders and to the public that its flagship product Real Scientific Hemp Oil™ (RSHO™) has been approved on a case-by-case basis for Parkinson’s disease by the Brazilian Government Health Agency ANVISA.
Medical Marijuana, Inc. Announces Investment in AXIM Biotechnologies
SAN DIEGO, June 30, 2015 /Weed Wire/ — Medical Marijuana, Inc. (OTC Pink:MJNA) would like to inform the public and shareholders that it holds 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies(AXIM), a cutting-edge biotechnology innovator.
The Truth About the US Government’s CBD Patent
The American government owns a CBD patent even though the plant that it comes from isn’t exactly legal on a federal level.
Thursday Watch for Actual Warning Signs
Cannabis stocks started the day under selling pressure. However, the negative pressure eased a bit as broader markets lifted higher.